Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2020 $ 10 $ 915,755 $ (900,869) $ (1,875) $ 13,021
Balance (in shares) at Mar. 31, 2020 10,286,366,000     57,577,000  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (4) (4)
Purchase of treasury stock (in shares)       3,442,000  
Vested restricted stock awards   4     4
Vested restricted stock awards (in shares) 16,126,000        
Stock-based compensation   210     210
Issuance of common stock, net of issuance costs $ 1 1,371     1,372
Issuance of common stock, net of issuance costs (in shares) 782,448,000        
Change in warrants valuation   99     99
Net loss     (1,823)   (1,823)
Balance at Jun. 30, 2020 $ 11 917,439 (902,692) $ (1,879) 12,879
Balance (in shares) at Jun. 30, 2020 11,084,940,000     61,019,000  
Balance at Mar. 31, 2021 $ 13 934,381 (919,271) $ (1,949) $ 13,174
Balance (in shares) at Mar. 31, 2021 12,898,144,000     73,954,000 12,824,190
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (29) $ (29)
Purchase of treasury stock (in shares)       3,353,000  
Vested restricted stock awards   29     29
Vested restricted stock awards (in shares) 19,096,000        
Stock-based compensation   305     305
Issuance of common stock, net of issuance costs $ 2 11,203     11,205
Issuance of common stock, net of issuance costs (in shares) 2,289,651,000        
Net loss     (2,182)   (2,182)
Balance at Jun. 30, 2021 $ 15 $ 945,918 $ (921,453) $ (1,978) $ 22,502
Balance (in shares) at Jun. 30, 2021 15,206,891,000     77,307,000 15,128,731